Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $
2010 $
2009 $
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.042B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.955B 12.68
Quest Diagnostics (DGX) United States $16.785B 17.21
DaVita (DVA) United States $13.482B 16.58
Encompass Health (EHC) United States $9.509B 23.39
Chemed (CHE) United States $8.752B 26.91
Elanco Animal Health (ELAN) United States $7.247B 16.29
RadNet (RDNT) United States $5.079B 120.47
Option Care Health (OPCH) United States $4.985B 24.50
Amedisys (AMED) United States $3.147B 22.51
Astrana Health (ASTH) United States $2.939B 41.59
LifeStance Health (LFST) United States $2.644B 0.00
Addus HomeCare (ADUS) United States $2.286B 27.76
U.S Physical Therapy (USPH) United States $1.222B 33.08
Pennant (PNTG) United States $1.000B 47.83
Aveanna Healthcare Holdings (AVAH) United States $0.875B 0.00
Atai Life Sciences (ATAI) Germany $0.195B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
Psychemedics (PMD) United States $0.013B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.013B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Novo Integrated Sciences (NVOS) United States $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00